Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Taiwania Capital is a prominent venture capital firm established in August 2017, backed by the National Development Fund of Taiwan's Executive Yuan and private enterprises. With a robust asset under management (AUM) of $865 million, the firm operates eight specialized funds and has a diverse portfolio of 75 companies. Taiwania Capital maintains offices in Taiwan, Silicon Valley, and Central/Eastern Europe, positioning itself strategically to foster partnerships and enhance Taiwan's economic growth through technology and capital linkage. The firm is led by a dedicated team of 55 professionals, including 16 partners, who bring a wealth of experience and expertise to the investment landscape. Taiwania Capital is recognized for its commitment to driving innovation and supporting startups that have the potential to transform industries, particularly in the technology and biotech sectors.
Taiwania Capital focuses on a wide array of sectors, including artificial intelligence (AI), software as a service (SaaS), fintech, healthcare, biotechnology, cybersecurity, robotics, semiconductor design, and generative AI. The firm primarily invests in Seed, Series A, and Series B stages, with average check sizes ranging from $5 million to $37 million. Their investment strategy emphasizes companies that demonstrate the potential for significant industry transformation, particularly in enterprise software, AI, and medical technology. Geographically, Taiwania Capital targets startups in Taiwan, the United States, Japan, Southeast Asia, and Central/Eastern Europe, leveraging its global networks to support portfolio companies in achieving market expansion and innovation.
Taiwania Capital boasts a diverse portfolio of 75 companies, including notable investments that have achieved significant market success. The firm has facilitated 14 initial public offerings (IPOs) and 4 acquisitions, showcasing its ability to identify and nurture high-potential startups. Among its standout portfolio companies are C4 Therapeutics, valued at $3.3 billion, Ambiq, which went public with a valuation of $409 million, and AEye, valued at $1.5 billion. Recent investments include Decube in January 2026, Resemble AI, and Arris Composites. Taiwania Capital operates multiple specialized funds, such as the Buffalo Fund focusing on technology and IoT, and the Life Sciences Fund dedicated to biotechnology, further diversifying its investment strategy and enhancing its impact across various sectors.
Dr. David Weng - Partner, focuses on investments in AI and biotech sectors, leveraging his extensive experience in technology commercialization.
Ms. Jane Lee - Partner, specializes in enterprise software and SaaS investments, with a strong background in startup growth strategies.
To pitch Taiwania Capital, founders should visit their contact page at taiwaniacapital.com or email dweng@taiwaniacapital.com. They accept both warm introductions and cold applications, and pitches should include a clear business model, market analysis, and team background.
Recently, Taiwania Capital has made headlines with its strategic investments in firms like Rakuten Medical, Path Robotics, and TXOne Networks, demonstrating its commitment to fostering innovation in the Asia Pacific region. The firm continues to expand its influence and support for portfolio companies, indicating a proactive approach to investment and growth.
Taiwania Capital invests in Seed, Series A, and Series B stages, with a particular focus on companies that demonstrate strong growth potential and innovation.
Founders can pitch Taiwania Capital by visiting their contact page at taiwaniacapital.com or by emailing dweng@taiwaniacapital.com. They welcome both warm introductions and cold applications.
The firm focuses on a variety of sectors, including AI, SaaS, fintech, healthcare, biotech, cybersecurity, robotics, and semiconductor design, among others.
Taiwania Capital typically invests between $5 million and $37 million in its portfolio companies, depending on the stage and potential of the startup.
Taiwania Capital invests globally, with a strong emphasis on North America, Asia, Taiwan, Japan, and Southeast Asia, as well as Central and Eastern Europe.
Startups interested in applying for investment can reach out through their website or via email. They encourage detailed pitches that outline the business model, market potential, and team background.
Taiwania Capital offers strategic partnerships and access to its extensive network to help portfolio companies expand their market reach and enhance their innovation capabilities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.